Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 9/2015

01-09-2015 | Retraction Note

Retraction Note to: A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells

Authors: Noriyuki Takai, Naoko Kira, Terukazu Ishii, Toshie Yoshida, Masakazu Nishida, Yoshihiro Nishida, Kaei Nasu, Masayuki Takano, Haruna Midori, Satoko Koga, Hisashi Narahara

Published in: Tumor Biology | Issue 9/2015

Login to get access

Excerpt

Retraction Note to: Tumor Biol. 33:1505–1510 …
Metadata
Title
Retraction Note to: A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells
Authors
Noriyuki Takai
Naoko Kira
Terukazu Ishii
Toshie Yoshida
Masakazu Nishida
Yoshihiro Nishida
Kaei Nasu
Masayuki Takano
Haruna Midori
Satoko Koga
Hisashi Narahara
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3646-1

Other articles of this Issue 9/2015

Tumor Biology 9/2015 Go to the issue

Research Article

ALDH1 might influence the metastatic capability of HeLa cells

Research Article

Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13

Retraction Note

Retraction Note to: Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis

Research Article

RETRACTED ARTICLE: Risperidone promotes differentiation of glioma stem-like cells through the Wnt signaling pathway

Research Article

ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells

Research Article

Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits